Harnessing the brain’s restorative power

Every day at Cognito I am inspired by our potential to help millions of patients living with neurodegenerative diseases via our breakthrough medical device. Building on three decades of MedTech experience, this is the most rewarding chapter of my career.

Kim Kwan, VP of Engineering

In my 20+ years in clinical research, I have never been more hopeful about a treatment. This novel treatment has the potential to dramatically improve outcomes for people worldwide who are suffering from the devastating impact of Alzheimer’s disease

Celine Houser, VP of Clinical Operations

Having worked on the foundational science underlying many of today’s leading Alzheimer’s treatments, I’m incredibly excited by the potential of Cognito’s novel mechanism and the promise of fundamentally changing the trajectory of the disease

Mihály Hajós, Chief Scientific Officer

I spent a substantial part of my career at some of the largest tech and medical device companies in the world. But at Cognito, I’m honored to have the chance to bring a novel product to patients who could realize a much-needed boosts to how we treat a devastating disease like Alzheimer's

Jennifer Newberger, VP of Regulatory & Compliance
Mission & Vision

We’re advancing the field of neuromodulation to create novel therapeutics that improve the lives of patients living with neurodegenerative diseases.

Our CEO Brent Vaughan’s recent fireside chat at the CNS Summit about game-changing neurotech to improve human cognition.

Screen Shot 2022 12 14 at 4 07 54 PM

Our Novel Platform

Introducing our novel platform for neurodegenerative disease

Our investigational medical device delivers non-invasive neuromodulation with the potential to improve outcomes in a range of neurodegenerative diseases, including Alzheimer’s disease.

Home platform card
Our Pipeline

Leveraging our platform across multiple neurodegenerative diseases.

Focus

CogTx-001

Alzheimer’s Disease

CogTx-002

MCI - Alzheimer’s Disease

CogTx-003

Parkinson’s Disease - Dementia

CogTx-004

Multiple Sclerosis

CogTx-005

Ischemic Stroke

Discovery

Preclinical

Early Clinical

Pivotal Clinical

In market

Latest News & Updates

Stay up to date

Designimage
Startup’s Headset to Treat Alzheimer’s Will Undergo Wide Trial With Patients
Fierceimage
Cognito's light-and-sound therapy slows brain tissue atrophy in Alzheimer's study
Economist77
Some health apps are able not just to diagnose diseases, but also to treat them
Article placeholder black
Gamma Sensory Stimulation Demonstrates Efficacy in Alzheimer Disease in New Analysis